老年维持性血液透析患者免疫功能低下。笔者从1994～1999年用胸腺因子D治疗此病,取得良好的疗效,报告如下。 1 对象与方法 1.1 对象 尿毒症患者25例,男16例,女9例,年龄60～72岁(平均65岁)。透析年限4～10年(平均6年),均采用重碳酸盐血液透析方式,每周2～3次,每次4～5 h,体内肝素化。用德国产 Immune dysfunction in elderly maintenance hemodialysis patients. The author from 1994 to 1999 with thymus factor D treatment of the disease, and achieved good results, the report is as follows. 1 Subjects and Methods 1.1 Object 25 cases of uremic patients, 16 males and 9 females, aged 60 to 72 years (mean, 65 years). Hemodialysis life of 4 to 10 years (average 6 years), all using bicarbonate hemodialysis, 2 to 3 times a week, each 4 ~ 5 h, heparinization in vivo. Made in Germany